Circulating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin.

about

Clinically-oriented proteomic investigation of sickle cell disease: Opportunities and challenges.Platelet haemostatic properties in β-thalassaemia: the effect of blood transfusion.

P2860

Q38837694-51B22B1A-1992-4A15-BB77-75B56F66CB02 Q41547084-338225BE-0D19-45F2-86F3-089156B2F811

P2860

Circulating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin.

Item

http://www.wikidata.org/entity/Q43111402

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Circulating microparticles in ...... emolysis and fetal hemoglobin.

@en

Circulating microparticles in ...... emolysis and fetal hemoglobin.

@nl

type

Item

label

Circulating microparticles in ...... emolysis and fetal hemoglobin.

@en

Circulating microparticles in ...... emolysis and fetal hemoglobin.

@nl

prefLabel

Circulating microparticles in ...... emolysis and fetal hemoglobin.

@en

Circulating microparticles in ...... emolysis and fetal hemoglobin.

@nl

P1476

Circulating microparticles in ...... emolysis and fetal hemoglobin.

@en

P2093

Alice Trinchero

http://www.w3.org/2001/XMLSchema#string

Anna Falanga

http://www.w3.org/2001/XMLSchema#string

P2860

Coagulation in the pathophysiology of hemolytic anemias.

Association of coagulation activation with clinical complications in sickle cell disease

Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin

Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children.

Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.

Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia.

Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease.

Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.

Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation.

Microparticles in tumor progression.

P304

995-997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3324/HAEMATOL.2013.085779

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

243969545

http://www.w3.org/2001/XMLSchema#string

P698

23813643

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3696592

http://www.w3.org/2001/XMLSchema#string

Circulating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin.

about

P2860

P2860

Circulating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932